QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文 THORACIC CANCER, 2021 作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan 收藏  |  浏览/下载：65/0  |  提交时间：2022/01/25 advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data   Systematic review and meta-analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanoma 期刊论文 CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 卷号: 44, 期号: 3 作者:  Chen, P.;  Chen, F.;  Zhou, B. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis 期刊论文 CUTANEOUS AND OCULAR TOXICOLOGY, 2019, 卷号: 38, 期号: 2 作者:  Chen, Peng;  Chen, Fucaho;  Zhou, Benhong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Dermatological toxicities  melanoma  risk  meta-analysis  BRAF inhibition  MEK inhibition